Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CON · against 233 other Healthcare companies of similar size
Ranked #72 of 234 · scores higher than 67% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 60–69, including CON · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | CON | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 232 reported | 3.9% | 2.4% | 70% | 30% | |
| EBITDA yieldHigher is better · 231 reported | 6.5% | 4.5% | 67% | 50% | |
| Free cash flow yieldHigher is better · 128 reported | 5.2% | 0.8% | 84% | 20% | |
| Book yieldHigher is better · 233 reported | 9.3% | 25.7% | 19% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 69 | 3.1B EUR (≈$3.4B) | 67 | 42 | |
| 69 | 170.4B THB (≈$4.8B) | 67 | 70 | |
| 69 | 74.2B SEK (≈$7.4B) | 67 | 55 | |
| 72 | 22.8B CNY (≈$3.2B) | 66 | 60 | |
| 72 | 5.1B USD | 66 | 54 | |
| 72 | 217.6B INR (≈$2.6B) | 66 | 67 | |
| 72 | 4.4B USD | 66 | 66 | |
| 72 | 3.2B USD | 66 | 65 | |
| 72 | 4.0B USD | 66 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score